Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1877156536;56537;56538 chr2:178599590;178599589;178599588chr2:179464317;179464316;179464315
N2AB1713051613;51614;51615 chr2:178599590;178599589;178599588chr2:179464317;179464316;179464315
N2A1620348832;48833;48834 chr2:178599590;178599589;178599588chr2:179464317;179464316;179464315
N2B970629341;29342;29343 chr2:178599590;178599589;178599588chr2:179464317;179464316;179464315
Novex-1983129716;29717;29718 chr2:178599590;178599589;178599588chr2:179464317;179464316;179464315
Novex-2989829917;29918;29919 chr2:178599590;178599589;178599588chr2:179464317;179464316;179464315
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Ig-116
  • Domain position: 84
  • Structural Position: 164
  • Q(SASA): 0.287
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/A None None 1.0 D 0.779 0.801 0.551344072312 gnomAD-4.0.0 1.63586E-06 None None None None I None 0 0 None 0 0 None 0 0 2.93681E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.7267 likely_pathogenic 0.6429 pathogenic -0.263 Destabilizing 1.0 D 0.779 deleterious D 0.579012855 None None I
G/C 0.8804 likely_pathogenic 0.8301 pathogenic -0.812 Destabilizing 1.0 D 0.812 deleterious None None None None I
G/D 0.9131 likely_pathogenic 0.8705 pathogenic -0.824 Destabilizing 1.0 D 0.857 deleterious None None None None I
G/E 0.9525 likely_pathogenic 0.9256 pathogenic -0.997 Destabilizing 1.0 D 0.833 deleterious D 0.565593266 None None I
G/F 0.9873 likely_pathogenic 0.9803 pathogenic -1.081 Destabilizing 1.0 D 0.837 deleterious None None None None I
G/H 0.9786 likely_pathogenic 0.9594 pathogenic -0.547 Destabilizing 1.0 D 0.823 deleterious None None None None I
G/I 0.985 likely_pathogenic 0.9692 pathogenic -0.463 Destabilizing 1.0 D 0.841 deleterious None None None None I
G/K 0.982 likely_pathogenic 0.9664 pathogenic -0.88 Destabilizing 1.0 D 0.833 deleterious None None None None I
G/L 0.9773 likely_pathogenic 0.9607 pathogenic -0.463 Destabilizing 1.0 D 0.831 deleterious None None None None I
G/M 0.9845 likely_pathogenic 0.9734 pathogenic -0.476 Destabilizing 1.0 D 0.811 deleterious None None None None I
G/N 0.9527 likely_pathogenic 0.9235 pathogenic -0.467 Destabilizing 1.0 D 0.829 deleterious None None None None I
G/P 0.9986 likely_pathogenic 0.9976 pathogenic -0.366 Destabilizing 1.0 D 0.865 deleterious None None None None I
G/Q 0.9574 likely_pathogenic 0.9287 pathogenic -0.783 Destabilizing 1.0 D 0.866 deleterious None None None None I
G/R 0.958 likely_pathogenic 0.9284 pathogenic -0.393 Destabilizing 1.0 D 0.867 deleterious D 0.630290883 None None I
G/S 0.6985 likely_pathogenic 0.595 pathogenic -0.543 Destabilizing 1.0 D 0.83 deleterious None None None None I
G/T 0.9379 likely_pathogenic 0.8932 pathogenic -0.66 Destabilizing 1.0 D 0.828 deleterious None None None None I
G/V 0.9653 likely_pathogenic 0.9352 pathogenic -0.366 Destabilizing 1.0 D 0.829 deleterious D 0.614876935 None None I
G/W 0.9843 likely_pathogenic 0.9728 pathogenic -1.235 Destabilizing 1.0 D 0.825 deleterious None None None None I
G/Y 0.9794 likely_pathogenic 0.9646 pathogenic -0.897 Destabilizing 1.0 D 0.836 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.